Skip to content

The influence of opioid-free anesthesia regimens on the postoperative recovery quality of patients undergoing arthroscopic shoulder surger

The influence of opioid-free anesthesia regimens on the postoperative recovery quality of patients undergoing arthroscopic shoulder surger

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115541
Enrollment
Unknown
Registered
2025-12-29
Start date
2025-12-29
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative recovery quality

Interventions

The non-opioid group:Anesthesia induction: dexmedetomidine 0.5µg/kg pumped within 10 minutes, esketamine 0.4mg/kg, propofol 2-2.5 mg/kg, cisatracurium 0.1-0.2mg/kg
Anesthesia maintenance: Esketamine at 0.25mg/kg/h was maintained until 30 minutes before the end of the surgery, dexmedetomidine at 0.1µg/kg/h was maintained until the end of the surgery, and propofol
Opioid Group:Anesthesia induction: Normal saline, sufentanil 0.4µg/kg, propofol 2-2.5mg/kg, cisatracurium 0.1-0.2mg/kg were pumped at the same volume and rate as dexmedetomidine. Anesthesia maintenanc

Sponsors

Yi Jishan Hospital,the First Affiliated Hospital of Wannan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Shoulder arthroscopic surgery will be performed under elective general anesthesia; (2) Age 18-65 years old; (3)BMI is 18-30 kg/m^2; (4) American society of Anesthesiologists (ASA) Grade I-III; (5) Clearly understand the experimental process and voluntarily participate, signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Patients who have been taking sedative and analgesic drugs for a long time due to pain; (2) Severe mental/cognitive impairment; (3) Severe heart, liver and kidney insufficiency, sick sinoatrial node syndrome, bradycardia (=180 mmHg or DBP>=100 mmHg); (7) Patients with hyperthyroidism; (8) Inability to communicate effectively or refusal to participate in research; (9)Patients who are allergic to or incompatible with any study drug and those participating in another intervention trial.

Design outcomes

Primary

MeasureTime frame
Postoperative recovery quality;

Secondary

MeasureTime frame
Hospital Anxiety and Depression Scale (HADS) score;NRS Pain score;The incidence of moderate to severe postoperative pain within 0-24 hours and 24-48 hours after the operation;The incidence of nausea and vomiting within 0-24 hours and 24-48 hours after the operation;The anesthesia recovery level of PACU, perioperative hemodynamics, and the occurrence frequency of hypertension and hypotension;Postoperative adverse reaction events;

Countries

China

Contacts

Public ContactYa Cao;Borui Li

Yiji Mountain Hospital, the First Affiliated Hospital of Wannan Medical College

3091573007@qq.com+86 187 1524 6590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026